Michael Lavelle
Cardiovascular Disease · New York, NYNPI 1699138263
Payments from drug & device makers
Across 362 payments — averaging $175.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$18K
- Medtronic$17K
- Abbott$14K
- Boston Scientific$13K
- Biosense Webster, Inc.$950
- Biotronik Inc.$762
- plus $1K from 10 others
What the payments were for
- Grants$47,49675%
- Travel & lodging$3,5206%
- Food & beverage$11,54818%
- Education$1,0322%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 1 | $17,500 |
| Medtronic | 26 | $16,905 |
| Abbott | 151 | $13,650 |
| Boston Scientific | 94 | $12,725 |
| Biosense Webster, Inc. | 54 | $950 |
| Biotronik Inc. | 17 | $762 |
| Astellas Pharma US Inc | 3 | $273 |
| Sanofi-aventis U.S. LLC | 2 | $241 |
| AstraZeneca | 2 | $155 |
| Abiomed | 1 | $125 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $106 |
| Novartis | 3 | $64 |
| Impulse Dynamics (USA) Inc. | 1 | $41 |
| Alnylam Pharmaceuticals Inc. | 1 | $36 |
| Scpharmaceuticals Inc. | 1 | $34 |
| Irhythm Technologies, Inc. | 1 | $26 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSITE PRECISION$1,666
- AVEIR$1,656
- EMBLEM MRI S-ICD$506
- LUX-Dx Insertable Cardiac Monitor$466
- GALLANT$365
- GENERAL - THERAPIES$266
- Micra$237
- EnSite Precision Cardiac Mapping System$184
- Acticor 7 VR-T DX$179
- WATCHMAN Access System$172
- Farapulse$169
- ENSITE$154
- JOT DX$154
- AMPLATZER AMULET$148
- AURORA EV-ICD MRI SURESCAN$143
- Carto 3$139
- FARXIGA$134
- Impella$125
How this compares
$63,595 in reported general payments places this provider in the 90th percentile of 2,302 cardiovascular disease providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Amiodarone Hcl | 26 | $1,078 |
| Metoprolol Succinate | 31 | $562 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in New York
- James MinNew York$41.1M
- Robert RosensonNew York$6.9M
- Roxana MehranNew York$6.4M
- Roger HajjarNew York$5.2M
- Philippe GenereuxNew York$4.4M
- Gregg StoneNew York$3.7M
- Valentin FusterNew York$2.9M
- Tamim NazifNew York$2.2M
- Howard WeintraubNew York$1.7M
- Anuradha Lala-TrindadeNew York$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.